ScoreWhy is Aarti Drugs Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate -8.44% of over the last 5 years
- OPERATING PROFIT TO INTEREST (Q) Lowest at 5.92 times
- PAT(Q) At Rs 40.54 cr has Fallen at -18.6% (vs previous 4Q average)
- INTEREST(Q) Highest at Rs 9.29 cr
2
Below par performance in long term as well as near term
- Along with generating -11.30% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Aarti Drugs for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Aarti Drugs
-11.3%
-0.26
43.98%
Sensex
7.07%
0.61
11.53%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.70%
EBIT Growth (5y)
-8.44%
EBIT to Interest (avg)
8.79
Debt to EBITDA (avg)
1.73
Net Debt to Equity (avg)
0.38
Sales to Capital Employed (avg)
1.45
Tax Ratio
4.37%
Dividend Payout Ratio
5.36%
Pledged Shares
0
Institutional Holding
12.27%
ROCE (avg)
16.64%
ROE (avg)
15.98%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
17
Industry P/E
32
Price to Book Value
2.33
EV to EBIT
16.39
EV to EBITDA
12.98
EV to Capital Employed
1.96
EV to Sales
1.58
PEG Ratio
0.50
Dividend Yield
NA
ROCE (Latest)
12.49%
ROE (Latest)
13.56%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
PAT(9M)
At Rs 139.73 cr has Grown at 32.70%
DEBT-EQUITY RATIO(HY)
Lowest at 0.39 times
-11What is not working for the Company
OPERATING PROFIT TO INTEREST (Q)
Lowest at 5.92 times
PAT(Q)
At Rs 40.54 cr has Fallen at -18.6% (vs previous 4Q average
INTEREST(Q)
Highest at Rs 9.29 cr
PBDIT(Q)
Lowest at Rs 55.03 cr.
OPERATING PROFIT TO NET SALES (Q)
Lowest at 9.15%
PBT LESS OI(Q)
Lowest at Rs 27.79 cr.
Loading Valuation Snapshot...
Here's what is working for Aarti Drugs
Debt-Equity Ratio - Half Yearly
Lowest at 0.39 times
in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Aarti Drugs
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 27.79 cr has Fallen at -49.3% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 54.82 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Operating Profit to Interest - Quarterly
Lowest at 5.92 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Profit After Tax (PAT) - Quarterly
At Rs 40.54 cr has Fallen at -18.6% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 49.78 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Interest - Quarterly
Highest at Rs 9.29 cr
in the last five quarters and Increased by 20.65 % (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs 55.03 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Lowest at 9.15%
in the last five quartersMOJO Watch
Company's efficiency has deteriorated
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 27.79 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
